drugset
drugset / Trial / NCT05362045

A Study to Evaluate the Effects on the Single-Dose Drug Levels of Mavacamten in Healthy Participants

NCT05362045 ↗

Phase 1 Completed 158 enrolled Bristol-Myers Squibb
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the effects on the single-dose drug levels of mavacamten in healthy participants.

Timeline

Start
2022-05-16
Primary completion
2022-08-19
Completion
2022-08-19

Drugs

EvaluationDrugModalityDoseRoute
Subject Mavacamten Small molecule — —

Indications

No indication recorded.